Nature Reviews Nephrology

Papers
(The H4-Index of Nature Reviews Nephrology is 62. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
A UMOD variant with intermediate effects694
Mentorship in the lives of scholars423
Kidney health within the broader non-communicable disease agenda378
Engineered CAR macrophages target kidney inflammation355
Making advance care planning easier for adults with kidney disease and their clinicians328
Age-old musings: twenty-first century management of advanced kidney disease in older individuals328
Role of the gut microbiota in the pathogenesis of IgA nephropathy315
The GLP-1 receptor agonist revolution comes to nephrology296
Uropathogen and host responses in pyelonephritis241
Designing acute kidney injury clinical trials228
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions226
Disaster preparedness for patients with kidney disease209
Endoplasmic reticulum-mediated organelle crosstalk in kidney disease189
Treatment of chronic kidney disease in older populations187
Vaccination in patients with kidney failure: lessons from COVID-19168
A single-cell atlas of DKD treatment responses163
Daprodustat for anaemia in CKD161
Roles of sensory receptors in non-sensory organs: the kidney and beyond160
Beyond state borders: transforming dialysis care for undocumented immigrants153
Genetic determinants of urine and plasma metabolite levels150
GWAS scorecard prioritizes kidney genes using coding and regulatory variants149
Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies146
Consideration of sex differences is necessary to achieve health equity141
Complosome — the intracellular complement system137
Phosphate sensing via PTC glycolysis135
Mutational signatures of ccRCC vary between geographical regions134
Publisher Correction: Sustainable Development Goals relevant to kidney health: an update on progress129
Reducing preventable acute kidney injury in a hospital setting129
Bringing Pride to nephrology129
Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups126
Increasing diversity and inclusion in nephrology clinical trials123
Clonal haematopoiesis and AKI123
The effects of sex hormone therapy on kidney function118
Informing clinical decision making during a pandemic — a call for better preparedness116
The roles of hyaluronan in kidney development, physiology and disease114
Menopause and chronic kidney disease113
Aquaporin water channels: roles beyond renal water handling109
Interferon blockade in lupus: effects on antiviral immunity109
Benefits of actin cytoskeleton stabilization105
Innovating dialysis through computational modelling of hollow-fibre haemodialysers102
From mapping kidney function to mechanism and prediction101
Identification of erythropoietin-producing cells99
NUAK1 promotes kidney fibrosis98
Design of a renal-sparing antifungal95
Tertiary lymphoid organs contribute to kidney allograft rejection93
Treatment of SLE with anti-CD19 CAR-T cells92
Heat and health inequity: acting on determinants of health to promote heat justice88
RNA-binding proteins and their role in kidney disease82
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)81
From fat to filter: the effect of adipose tissue-derived signals on kidney function80
The role of complement in kidney disease80
Long-term health outcomes associated with hydration status79
Salt substitution: opportunities and challenges for nephrology77
Neutrophils and NETs in kidney disease74
Pathological mechanisms of kidney disease in ageing74
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework70
Reaping the rewards of mechanistic discovery in glomerular disease70
The evolving landscape of immune-mediated glomerular diseases70
A golden year of innovative kidney disease therapeutics67
An integrated approach towards a public health perspective on chronic kidney disease65
MSC therapy for diabetic kidney disease and nephrotic syndrome65
Network medicine: an approach to complex kidney disease phenotypes64
A pathway of osmotic stress-induced necroptosis62
0.03922700881958